Use of a PPE in a DMC

The use of appropriate Personal Protective Equipment (PPE) in a TB laboratory is determined by risk assessment (according to the procedure and suspected pathogen).

 

Designated Microscopy Centres (DMCs) are low-risk TB laboratories, hence PPE should be used as follows:

How to communicate results to TB patient

When the referring health facility receives the test results from the DMC, the results are communicated to the patient through NTEP supervisors/health facility staff/Medical Officer.

Both Positive and negative results need to be communicated to the patient. For negative results, counselling for further evaluation and testing need to be done for the symptoms.

Communication as a tool embodies attitudes, behavior, body language, style, method of presentation, quality of listening and perceptions and interpretations.

TB Treatment Initiation

The Medical Officer (MO) of the referring health facility initiates TB treatment on receipt of the diagnostic test results. All efforts are made to initiate the treatment at the earliest.

The treatment regimen is decided based on the type of patient and TB (based on drug sensitivity pattern, i.e., drug-sensitive TB or H-mono/ poly resistance, history of adverse drug reaction to anti-TB drugs).

Subscribe to